Composition
- Active ingredients
- DOLASETRON MESYLATE 500MG/25ML (20MG/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- DOLASETRON MESYLATE 50MG · TabletNDA020623-001 · Discontinued
- DOLASETRON MESYLATE 100MG · TabletNDA020623-002 · Discontinued
- DOLASETRON MESYLATE 500MG/25ML (20MG/ML) · InjectableThis page
- DOLASETRON MESYLATE 100MG/5ML (20MG/ML) · InjectableNDA020624-001 · Discontinued
- DOLASETRON MESYLATE 12.5MG/0.625ML (20MG/ML) · InjectableNDA020624-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020624.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Anzemet
- Active substance
- dolasetron mesylate
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Validus Pharms
- Status
- Discontinued
- FDA approval
- 11 Sept 1997
- Application
- NDA020624-003